These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24934043)

  • 1. [Female sex hormones. Good or bad for blood vessels?].
    Stiefelhagen P
    MMW Fortschr Med; 2014 Feb; 156(2):30. PubMed ID: 24934043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone therapy and cardiovascular risk].
    Wütschert R; Cirafici P
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies.
    Boldo A; White WB
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):419-32, ix. PubMed ID: 21565676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
    Bershteĭn LM
    Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors].
    Lauritzen C
    Zentralbl Gynakol; 1990; 112(17):1071-90. PubMed ID: 2264417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Veno-lymphatic insufficiency. 4,729 patients undergoing hormonal and procyanidol oligomer therapy].
    Henriet JP
    Phlebologie; 1993; 46(2):313-25. PubMed ID: 8362014
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogens and thrombosis.
    Schrogie JJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):526. PubMed ID: 18323862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists].
    Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
    Kardiol Pol; 2007 Nov; 65(11):1331-46; discussion 1347-49. PubMed ID: 18303601
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular diseases with oral contraceptives: risks and benefits].
    Heinemann L
    Z Arztl Fortbild (Jena); 1990; 84(1-2):43-6. PubMed ID: 2184599
    [No Abstract]   [Full Text] [Related]  

  • 10. Contraceptive for obese women: considerations.
    Kelsey B
    Nurse Pract; 2010 Mar; 35(3):24-31; quiz 31-2. PubMed ID: 20164732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal contraceptives and their relationship to breast cancer].
    Habánová M; Svikruhová J; Sláviková E
    Klin Onkol; 2010; 23(6):428-32. PubMed ID: 21351420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The taking of sex hormone preparations and the risk of developing breast cancer].
    Levshin VF
    Vopr Onkol; 1992; 38(8):899-909. PubMed ID: 1300798
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormonal replacement therapy and oral contraception. Risk of induction or reactivation of gynecologic malignancies].
    Kimmig R; Seehaus D; Scheidel P; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1995; 35(2):72-8. PubMed ID: 7620385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Venous and arterial thrombotic events induced by synthetic-steroid hormones or oral contraceptives].
    Sugawara H; Kawakami M
    Nihon Rinsho; 1999 Jul; 57(7):1657-64. PubMed ID: 10429474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The risk of hormone therapy in women with vascular risks].
    Drapier-Faure E
    Contracept Fertil Sex; 1994; 22(7-8):429-33. PubMed ID: 7920943
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis of the effects on hormone replacement therapy and oral contraceptives associated with female lung cancer risk].
    Chen X; Cai L
    Wei Sheng Yan Jiu; 2009 Nov; 38(6):672-6. PubMed ID: 20047219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.